{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:33:07Z","timestamp":1793665987033,"version":"4.5.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rho-kinase inhibitors can inhibit fibrosis after glaucoma surgery. This study aimed to evaluate the effect of rho-kinase inhibitor after needling procedure with mitomycin C for the failure of filtering bleb with trabeculectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective single-center study examined the effects of rho-kinase inhibitor after the needling procedure. We included 27 eyes of 27 patients with glaucoma who underwent needling procedure using mitomycin C and were subsequently treated with ripasudil\u2014a rho-associated protein kinase inhibitor (ripasudil group)\u2014or without ripasudil (control group). The ripasudil and control groups were compared in terms of intraocular pressure (IOP) and the number of antiglaucoma medications. Success at 12\u00a0months after the needling procedure was defined as a\u2009&gt;\u200920% decrease in IOP from the preoperative period without surgical reintervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At 12\u00a0months after the needling procedure, the mean IOP decreased from 16.9\u2009\u00b1\u20094.5 to 12.6\u2009\u00b1\u20091.1\u00a0mmHg in the control group and from 16.0\u2009\u00b1\u20095.3 to 12.2\u2009\u00b1\u20091.2\u00a0mmHg in the ripasudil group (<jats:italic>p<\/jats:italic>\u2009=\u20090.77). The 12-month success rates were 60.00% and 56.25% in the control and ripasudil groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.98), respectively. In the preoperative period, the numbers of antiglaucoma drugs were 0.27\u2009\u00b1\u20090.46 and 0.92\u2009\u00b1\u20090.91 in the control and ripasudil groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.022), respectively, and at 12\u00a0months after the needling procedure, they were 1.07\u2009\u00b1\u20091.44 and 0.73\u2009\u00b1\u20091.10 (<jats:italic>p<\/jats:italic>\u2009=\u20090.52), respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Treatment with ripasudil (a rho-associated protein kinase inhibitor) after the needling procedure with mitomycin C did not show better results than treatment with the mitomycin C needling procedure alone at 12\u00a0months after the procedure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02680-9","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:02:58Z","timestamp":1668438178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yu","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Tokumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Okumichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"2680_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archopht.1981.03930010635009","volume":"99","author":"HA Quigley","year":"1981","unstructured":"Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. the site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99:635\u201349.","journal-title":"Arch Ophthalmol."},{"key":"2680_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE. Trabeculectomy. preliminary report of a new method. Am J Ophthalmol. 1968;66:673\u20139.","journal-title":"Am J Ophthalmol."},{"key":"2680_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0039-6257(87)90091-9","volume":"32","author":"GL Skuta","year":"1987","unstructured":"Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149\u201370.","journal-title":"Surv Ophthalmol"},{"key":"2680_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","volume":"10","author":"DC Broadway","year":"2001","unstructured":"Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001;10:237\u201349.","journal-title":"J Glaucoma"},{"key":"2680_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0002-9394(14)76340-8","volume":"110","author":"RH Ewing","year":"1990","unstructured":"Ewing RH, Stamper RL. Needle revision with and without 5-fluorouracil for the treatment of failed filteringblebs. Am J Ophthalmol. 1990;110:254\u20139.","journal-title":"Am J Ophthalmol"},{"key":"2680_CR6","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/S0161-6420(96)30403-X","volume":"103","author":"PG Mardelli","year":"1996","unstructured":"Mardelli PG, Lederer CM, Murray PL, Pastor SA, Hassanein KM. Slit-lamp needle revision of failed filtering blebs using Mitomycin C. Ophthalmology. 1996;103:1946\u201355.","journal-title":"Ophthalmology"},{"key":"2680_CR7","doi-asserted-by":"publisher","first-page":"4310258","DOI":"10.1155\/2020\/4310258","volume":"2020","author":"X Chen","year":"2020","unstructured":"Chen X, Suo L, Hong Y, Zhang C. Safety and efficacy of bleb needling with antimetabolite after trabeculectomy failure in glaucoma patients: A systemic review and meta-analysis. J Ophthalmol. 2020;2020:4310258. https:\/\/doi.org\/10.1155\/2020\/4310258 eCollection 2020.","journal-title":"J Ophthalmol."},{"key":"2680_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ajo.2013.05.016","volume":"156","author":"H Tanihara","year":"2013","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Araie M, et al. Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 2013;156:731\u20136.","journal-title":"Am J Ophthalmol"},{"key":"2680_CR9","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1111\/aos.12599","volume":"93","author":"H Tanihara","year":"2015","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Suganami H, et al. Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary openangle glaucoma and ocular hypertension: A randomized, open-label, crossover study. Acta Ophthalmol. 2015;93:e254\u201360.","journal-title":"Acta Ophthalmol"},{"key":"2680_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10384-018-0566-9","volume":"62","author":"M Honjo","year":"2018","unstructured":"Honjo M, Tanihara H. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma. Jpn J Ophthalmol. 2018;62:109\u201326.","journal-title":"Jpn J Ophthalmol"},{"key":"2680_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12325-018-0863-1","volume":"36","author":"H Tanihara","year":"2019","unstructured":"Tanihara H, Kakuda T, Sano T, Kanno T, Imada R, Shingaki W, et al. Safety and efficacy of Ripasudil in Japanese Patients with glaucoma or ocular hypertension: 3-month interim analysis of ROCK-J a post-marketing surveillance study. Adv Ther. 2019;36:333\u201343.","journal-title":"Adv Ther"},{"key":"2680_CR12","doi-asserted-by":"publisher","first-page":"19640","DOI":"10.1038\/srep19640","volume":"6","author":"Y Kaneko","year":"2016","unstructured":"Kaneko Y, Ohta M, Inoue T, Mizuno K, Isobe T, Tanabe S, et al. Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm\u2019s canal endothelial cells. Sci Rep. 2016;6:19640.","journal-title":"Sci Rep"},{"key":"2680_CR13","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1167\/iovs.07-0878","volume":"12","author":"M Honjo","year":"2007","unstructured":"Honjo M, Tanihara H, Kameda T, Kawaji T, Yoshimura N, Araie M. Potential role of Rhoassociated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2007;12:5549\u201357. https:\/\/doi.org\/10.1167\/iovs.07-0878.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2680_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.exer.2016.07.001","volume":"149","author":"A Futakuchi","year":"2016","unstructured":"Futakuchi A, Inoue T, Fujimoto T, Inoue-Mochita M, Kawai M, Tanihara H. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts. Exp Eye Res. 2016;149:107\u201315.","journal-title":"Exp Eye Res"},{"key":"2680_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.ijg.0000146364.90506.7c","volume":"14","author":"RK Shetty","year":"2005","unstructured":"Shetty RK, Wartluft L, Moster MR. Slit-lamp needle revision of failed filtering blebs using high-dose Mitomycin C. J Glaucoma. 2005;14:52\u20136. https:\/\/doi.org\/10.1097\/01.ijg.0000146364.90506.7c.","journal-title":"J Glaucoma"},{"key":"2680_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/IJG.0b013e318181283e","volume":"17","author":"RM Feldman","year":"2008","unstructured":"Feldman RM, Tabet RR. Needle revision of filtering blebs. J Glaucoma. 2008;17:594\u2013600. https:\/\/doi.org\/10.1097\/IJG.0b013e318181283e.","journal-title":"J Glaucoma"},{"key":"2680_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0039-6257(00)00135-1","volume":"45","author":"L Chang","year":"2000","unstructured":"Chang L, Crowston JG, Cordeiro MF, Akbar AN, Khaw PT. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol. 2000;45:49\u201368. https:\/\/doi.org\/10.1016\/s0039-6257(00)00135-1.","journal-title":"Surv Ophthalmol"},{"key":"2680_CR18","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/art.23677","volume":"58","author":"A Akhmetshina","year":"2008","unstructured":"Akhmetshina A, Dees C, Pileckyte M, Szucs G, Spriewald BM, Zwerina J, Distler O, Schett G, Distler JH. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts. Arthritis Rheum. 2008;58:2553\u201364. https:\/\/doi.org\/10.1002\/art.23677.","journal-title":"Arthritis Rheum"},{"key":"2680_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cbf.3382","volume":"37","author":"DG Ibrahim","year":"2019","unstructured":"Ibrahim DG, Ko JA, Iwata W, Okumichi H, Kiuchi Y. An in vitro study of scarring formation mediated by human Tenon fibroblasts: effect of Y-27632, a Rho kinase inhibitor. Cell Biochem Funct. 2019;37:113\u201324. https:\/\/doi.org\/10.1002\/cbf.3382.","journal-title":"Cell Biochem Funct"},{"key":"2680_CR20","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/archopht.1977.04450090134011","volume":"95","author":"JS Cohen","year":"1977","unstructured":"Cohen JS, Shaffer RN, Hetherington J, Hoskins D. Revision of filtration surgery. Arch Ophthalmol. 1977;95:1612\u20135.","journal-title":"Arch Ophthalmol"},{"key":"2680_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0161-6420(01)01016-8","volume":"109","author":"AS Hawkins","year":"2002","unstructured":"Hawkins AS, Flanagan JK, Brown SV. Predictors for success of needle revision of failing filtration blebs. Ophthalmology. 2002;109:781\u20135.","journal-title":"Ophthalmology"},{"key":"2680_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0002-9394(01)01232-6","volume":"132","author":"DH Shin","year":"2001","unstructured":"Shin DH, Kim YY, Ginde SY, Kim PH, Eliassi-Rad B, Khatana AK, Keole NS. Risk factors for failure of 5-fluorouracil needling revision for failed conjunctival filtration blebs. Am J Ophthalmol. 2001;132:875\u201380.","journal-title":"Am J Ophthalmol"},{"key":"2680_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0002-9394(14)72010-0","volume":"122","author":"DS Greenfield","year":"1996","unstructured":"Greenfield DS, Miller MP, Suner IJ, Palmberg PF. Needle elevation of the scleral flap for failing filtration blebs after trabeculectomy with Mitomycin C. Am J Ophthalmol. 1996;122:195\u2013204.","journal-title":"Am J Ophthalmol"},{"key":"2680_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00061198-200604000-00004","volume":"15","author":"C Guti\u00e9rrez-Ortiz","year":"2006","unstructured":"Guti\u00e9rrez-Ortiz C, Cabarga C, Teus M. Prospective evaluation of preoperative factors associated with successful Mitomycin C needling of failed filtration blebs. J Glaucoma. 2006;15:98\u2013102.","journal-title":"J Glaucoma"},{"key":"2680_CR25","first-page":"OP342","volume":"79","author":"K Swan","year":"1975","unstructured":"Swan K. Reopening of nonfunctioning filters\u2013Simplified surgical techniques. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975;79:OP342-8.","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol."},{"key":"2680_CR26","doi-asserted-by":"publisher","first-page":"e18743641220620","DOI":"10.2174\/18743641-v16-e2206201","volume":"16","author":"T Mimura","year":"2022","unstructured":"Mimura T, Noma H, Inoue Y, Kawashima M, Kitsu K, Mizota A. Early postoperative effect of ripasudil hydrochloride after trabeculectomy on secondary glaucoma: a randomized controlled trial. Open J Ophthalmol. 2022;16:e187436412206201. https:\/\/doi.org\/10.2174\/18743641-v16-e2206201.","journal-title":"Open J Ophthalmol"},{"key":"2680_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s0039-6257(03)00038-9","volume":"48","author":"PJ Lama","year":"2003","unstructured":"Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48:314\u201346. https:\/\/doi.org\/10.1016\/s0039-6257(03)00038-9.","journal-title":"Surv Ophthalmol"},{"issue":"Supplement 1","key":"2680_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12886-015-0134-8","volume":"15","author":"O Yamanaka","year":"2015","unstructured":"Yamanaka O, Kitano-Izutani A, Tomoyose K, Reinach PS. Pathobiology of wound healing after glaucoma filtration surgery. BMC Ophthalmol. 2015;15(Supplement 1):157. https:\/\/doi.org\/10.1186\/s12886-015-0134-8.","journal-title":"BMC Ophthalmol"},{"key":"2680_CR29","doi-asserted-by":"publisher","first-page":"4310258","DOI":"10.1155\/2020\/4310258","volume":"2020","author":"X Chen","year":"2020","unstructured":"Chen X, Suo L, Hong Y, Zhang C. Safety and efficacy of bleb needling with antimetabolite after trabeculectomy failure in glaucoma patients: a systemic review and meta-analysis. J Ophthalmol. 2020;2020:4310258. https:\/\/doi.org\/10.1155\/2020\/4310258.","journal-title":"J Ophthalmol"},{"key":"2680_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3928\/15428877-20111129-02","volume":"43","author":"R Dalvi","year":"2012","unstructured":"Dalvi R, Orzech N, Kranemann C, Birt CM. Five-year results of 5-fluorouracil augmented needling revision of failing blebs. Ophthalmic Surg Lasers Imaging. 2012;43:32\u20138. https:\/\/doi.org\/10.3928\/15428877-20111129-02.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2680_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol. 1994;112:1437\u201345.","journal-title":"Arch Ophthalmol."},{"key":"2680_CR32","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication II The outcome of filtration surgery. Arch Ophthalmol. 1994;112:1446\u201354.","journal-title":"Arch Ophthalmol."},{"issue":"12","key":"2680_CR33","doi-asserted-by":"publisher","first-page":"e0181550","DOI":"10.1371\/journal.pone.0181550","volume":"20","author":"T Miki","year":"2017","unstructured":"Miki T, Naito T, Fujiwara M, Araki R, Kiyoi R, Shiode Y, Fujiwara A, Morizane Y, Shiraga F. Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy. PLoS ONE. 2017;20(12):e0181550. https:\/\/doi.org\/10.1371\/journal.pone.0181550.","journal-title":"PLoS ONE"},{"key":"2680_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/bjo.67.10.661","volume":"67","author":"AO Akingbehin","year":"1983","unstructured":"Akingbehin AO. Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br J Ophthalmol. 1983;67:661\u20133. https:\/\/doi.org\/10.1136\/bjo.67.10.661.","journal-title":"Br J Ophthalmol."},{"key":"2680_CR35","first-page":"170","volume":"26","author":"RN Weinreb","year":"1985","unstructured":"Weinreb RN, Polansky JR, Kramer SG, Baxter JD. Acute effects of dexamethasone on intraocular pressure in glaucoma. Invest Ophthalmol Vis Sci. 1985;26:170\u20135.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02680-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:10:19Z","timestamp":1668438619000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02680-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2680"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02680-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was received approval from the Ethical Committee for Epidemiology of Hiroshima University (protocol code E\u20142142, August 6, 2020), and the research adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}